New research indicates that
people with dementia could benefit
from a daily dose of vitamin E.
In a cooperative randomised trial
studying 561 patients with mild
to moderate Alzheimer’s Disease
(AD) and published in the Journal of
the American Medical Association,
vitamin E (alpha tocopherol) and
or memantine were evaluated for
slowing of functional decline.
2000 IU/d of alpha tocopherol
compared with placebo was
demonstrated to slow decline and
reduce caregiver burden suggesting
a role in mild to moderate AD.
There were no significant
differences in the groups receiving
memantine alone or memantine
plus alpha tocopherol (vitamin E).
CLICK HERE to read the abstract.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jan 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.